ReviewStem cell research & therapy2017

CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?

Dario Gerace et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.